-
InDex Pharmaceuticals announces positive results from a pharmacokinetic (PK) study with cobitolimod
March 15, 2023 Non Regulatory
-
InDex Pharmaceuticals to attend the ECCO 2023 congress
February 27, 2023 Non Regulatory
InDex Pharmaceuticals published its year-end report for 2022 on February 23 2023 at 08:00 a.m. CET.
-
Annual Report 2022
-
Presentation at Redeye Investor Forum Göteborg
-
Interim Report Q1 2023